drugset / Trial / NCT01943136

The Efficacy and Safety of Topical Papaya (Carica Papaya) Leaf Extract 1% Ointment Versus Mupirocin 2% Ointment in the Treatment of Limited Impetigo: a Randomized, Double-blind, Controlled Clinical Trial

NCT01943136

RandomizedParallel-groupTriple-blindTreatment

Summary

This study will be an investigator-blinded, patient-blinded, assessor-blinded, parallel-group, randomized clinical trial. It aims to evaluate the efficacy of one-week twice-daily application of topical papaya leaf extract ointment compared to mupirocin ointment in achieving clinical cure among patients with impetigo.

Timeline

Start
2013-08
Primary completion
2015-06
Completion

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Carica Papaya Leaf Extract Unknown 1 % Topical
Comparator Mupirocin Small molecule 2 % Topical

Indications